Buy ScyFIX 700, ScyFIX 600 and Accessories on-line

Welcome to ScyFIX web shop where you can order ScyFIX MCN products, choose payment method, including a secure on-line credit card payment service (SSL), and check your delivery status on-line. Buying on-line is safe and easy and you will be guided all the way. All prices are in € (Euro). Place your order and your credit card company will convert the amount in € to your own currency. We accept Visa, Master Card, EuroCard and most bank cards connected to VISA or Master Card. Follow the instructions to take you through the pages, and then onto a secure site in which you will input your credit card and shipping details. When bank authorization has been attained, you will be get a confirmation on-line, as well as a confirming e-mail. If at any stage you wish to change your order, just click the "Remove"-button.

All customers who have bought the ScyFIX 600 device are offered to upgrade to the 700 system at a discount.

Sales of the ScyFIX 600 products is administered by Prospectus AB, Stockholm, Sweden (EU). For any ScyFIX 600 sales or customer service questions, please contact Prospectus, proud proprietor and distributor of all ScyFIX 600 products and accessories. If you are a US resident and want to know more about our therapy, please send an inquiry by e-mail to our European office support@scyfix.org, or fill in your personal information in our Clinical Trial & Purchase Interest Form by clicking here www.scyfix.org/clinical_trial_form.htm.

For current exchange rates we recommend the web site www.oanda.com/convert/classic.

 

ScyFIX 600 MCN Therapy Kit (Outside Europe)

The ScyFIX 600 Therapy Kit includes a ScyFIX 600 micro current neuromodulator, wires, set of 12 pads with electrodes (6-8 months), nutritional supplements (6 months), 3 AC/DC adapters (EU/UK/US standards), instruction manual in English and the booklet "Don't Go Blind".
Price: 990€ Add to cart

  ScyFIX 600 MCS Therapy Kit (Europe)

The ScyFIX 600 Therapy Kit includes a ScyFIX 600 micro current neuromodulator, wires, set of 12 pads with electrodes (6-8 months), nutritional supplements (6 months), AC/DC adapter (EU standard), instruction manual in English and the booklet "Don't Go Blind".
Price: 890€ Add to cart

ScyFIX 700 - Upgrade for ScyFIX 600 Users

Existing customers using the ScyFIX 600 can upgrade to the ScyFIX 700 at a discount of 1000 € + an extra 595 € when returning the ScyFIX 600. (When the 700 is available for delivery, the price is expected to be 4995 Euros.) Order now and you will become one of the first to benefit from this new revolutionary technology. The ScyFIX 700 can be delivered early winter 2010. The ScyFIX 700 Therapy Kit includes a ScyFIX 700 micro current neuromodulator, wires, set of 12 pads with electrodes (6-8 months), nutritional supplements (6 months), AC/DC adapter (EU standard), instruction manual in English and the booklet "Don't Go Blind".
Price: 3400€ Add to cart

  ScyFIX 700 - New customers

New customers are offered to purchase the new ScyFIX 700 at a discount of 1000 €, when ordering before June 30, 2009. (When the 700 is available for delivery, the price is expected to be 4995 Euros.) Order now and you will become one of the first to benefit from this new revolutionary technology. The ScyFIX 700 can be delivered early winter 2010. The ScyFIX 700 Therapy Kit includes a ScyFIX 700 micro current neuromodulator, wires, set of 12 pads with electrodes (6-8 months), nutritional supplements (6 months), AC/DC adapter (EU standard), instruction manual in English and the booklet "Don't Go Blind".
Price: 3995€ Add to cart

Pads

Pads, new improved quality. Price per set of 12. Each set of pads lasts maximum one month.
Price: 160€ Add to cart

  US and UK AC/DC Adaptor

AC/DC Adaptors for US and UK standard sockets. (European EU adaptor is included as standard.)
Price: 40€ Add to cart

Lead wires

Replacement lead wires to connect pads with device.
Price: 20€ Add to cart

  Patient guide "Don't Go Blind" - book about AMD, RP, and the MCN Therapy

This booklet is for people with blindness related diseases and their families and friends. It provides information about Age Related Macular Degeneration Retinitis Pigmentosa, and answers questions about causes, symptoms and therapies, e.g. micro-current stimulation.
Price: 15€ Add to cart

Nutritional supplements. New formula!

A specially designed combination of nutritional supplements for 6 months with essential nutrients and antioxidants, including vitamins A, C, E, Copper, Zinc, Omega-3 fatties EPA, DHA and GLA, Lutein, Selenium, Blueberry Extract and others, all proven to have positive effects on the function of the eye in many studies and practice. Should you already take nutritional supplements, we advise you to contact your doctor or pharmacist.
Price: 200€ Add to cart

 

 

Your cart

Your cart is empty

 

Information

The above prices are only valid for direct sale to patients over the web shop. Air Mail shipping is included in all prices. Products will be shipped from Prospectus AB (global distributor of ScyFIX 600 products) within seven (7) days from the day that full payment has been received. Any other costs, e.g. Customs/ Import/ Entry Duty or Taxes, VAT and other locally imposed duties or taxes in the buyer's Country, will be additional and have to be paid for locally by the buyer.

 
     

Breaking News! The ScyFIX 700 MCN Therapy is the only patented Micro Current Neuromodulation (MCN) device approved in Europe for the treatment of Retinitis Pigmentosa. Compelling Clinical Results: Retinitis Pigmentosa (RP) is a degenerative disease, and improvement in visual fields, visual acuity, or contrast sensitivity is not expected. In the RP trial, best corrected visual acuity either improved or remained stable in 94% of patients and improved in 22% of the population. Visual field improved in 63% of the patients. Patients are now using mobile phones, reading newspapers, seeing faces of family members and threading needles, none of these day to day activities were possible for these patients before using the ScyFIX MCN device. Similar compelling results have been achieved in our Dry Age-Related Macular Degeneration (“ARMD”) trial as well.